​

InflaRx (IFRX) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

IFRX Stock Forecast

InflaRx (IFRX) stock forecast, based on 2 Wall Street analysts, predicts a 12-month average price target of $6.00, with a high of $6.00 and a low of $6.00. This represents a 167.86% increase from the last price of $2.24.

$1 $2 $3 $4 $5 $6 High: $6 Avg: $6 Low: $6 Last Closed Price: $2.24

IFRX Stock Rating

InflaRx stock's rating consensus is Strong Buy, based on 2 Wall Street analysts. The breakdown includes 1 Strong Buy (50.00%), 1 Buy (50.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Strong Buy
Total 2 0 1 1 Strong Sell Sell Hold Buy Strong Buy

IFRX Forecast vs Benchmarks

TypeNameUpside
StockInflaRx167.86%
SectorHealthcare Stocks 25.20%
IndustryBiotech Stocks 63.35%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$2.24$2.24$2.24
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 25131--5
Dec, 24131--5
Nov, 24131--5
Oct, 24331--7
Sep, 24331--7
Latest Price Target by Analysts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jan 06, 2023H.C. Wainwright$6.00$2.92105.48%167.86%
Latest Upgrade/Downgrade by Analysts
DateCompanyPrevious RatingNew RatingRating Change
Apr 06, 2023Raymond JamesStrong BuyStrong Buyhold
Apr 05, 2023GuggenheimBuyupgrade

Financial Forecast

EPS Forecast

Dec 20 Dec 21 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.26$-1.10$-0.76-----
Avg Forecast$-1.11$-1.05$-0.69$-0.93$-0.97$-0.78$-0.20$0.26
High Forecast$-2.60$-2.46$-0.73$-0.94$-1.09$-1.57$-0.41$0.03
Low Forecast$-0.11$-0.11$-0.64$-0.91$-0.84$-0.09$-0.02$0.53
Surprise %13.51%4.76%10.14%-----

Revenue Forecast

$0 $50M $100M $150M $200M $250M Dec 20 Dec 21 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported--$61.80K-----
Avg Forecast$31.96K$4.31M$4.49M$217.94K$771.30K$17.97M$82.09M$139.92M
High Forecast$9.91K$1.34M$1.12M$90.81K$192.82K$5.68M$25.97M$44.26M
Low Forecast$65.10K$8.78M$11.15M$335.99K$1.42M$32.07M$146.52M$249.75M
Surprise %---98.62%-----

Net Income Forecast

$-150M $-110M $-70M $-30M $10M $50M Dec 20 Dec 21 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-34.01M$-45.65M$-41.79M-----
Avg Forecast$-60.95M$-57.63M$-37.88M$-50.85M$-53.22M$-42.61M$-11.23M$14.46M
High Forecast$-143.11M$-135.33M$-39.93M$-51.83M$-60.10M$-86.10M$-22.70M$1.61M
Low Forecast$-6.30M$-5.95M$-35.32M$-49.87M$-46.33M$-4.74M$-1.25M$29.21M
Surprise %-44.20%-20.78%10.32%-----

IFRX Forecast FAQ

Is InflaRx stock a buy?

InflaRx stock has a consensus rating of Strong Buy, based on 2 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 1 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that InflaRx is a good investment for most analysts.

What is InflaRx's price target?

InflaRx's price target, set by 2 Wall Street analysts, averages $6 over the next 12 months. The price target range spans from $6 at the low end to $6 at the high end, suggesting a potential 167.86% change from the previous close price of $2.24.

How does InflaRx stock forecast compare to the average forecast of its sector, industry, and investment themes?

InflaRx stock forecast shows a 167.86% upside, outperforming the average forecast for the healthcare stocks sector (25.20%) and outperforming the biotech stocks industry (63.35%).

What is the breakdown of analyst ratings for InflaRx over the past three months?

  • January 2025: 20.00% Strong Buy, 60.00% Buy, 20.00% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 20.00% Strong Buy, 60.00% Buy, 20.00% Hold, 0% Sell, 0% Strong Sell.
  • November 2024: 20.00% Strong Buy, 60.00% Buy, 20.00% Hold, 0% Sell, 0% Strong Sell.

What is InflaRx’s EPS forecast?

InflaRx's average annual EPS forecast for its fiscal year ending in December is -0.93 for 2024, a 22.37% increase from the reported $-0.76 in 2023. The prediction for 2025 is $-0.97, $-0.78 for 2026, $-0.2 for 2027, and $0.26 for 2028.

What is InflaRx’s revenue forecast?

InflaRx's average annual revenue forecast for its fiscal year ending in December is $217.94K for 2024, a 252.68% increase from the reported $61.8K in 2023. The forecast for 2025 is $771.3K, $17.97M for 2026, $82.09M for 2027, and $139.92M for 2028.

What is InflaRx’s net income forecast?

For its fiscal year ending in December, InflaRx's average annual net income forecast is $-50.852M for 2024, reflecting an 21.68% increase from the reported $-41.793M in 2023. The projection for 2025 is $-53.216M, $-42.612M for 2026, $-11.235M for 2027, and $14.46M for 2028.